Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-06-17

Clinical Trial Update: Cipralex in Treatment of Depressive Symptoms and Chronic Back Pain [Phase 4]

View source ↗

Summary

The Phase 4 clinical trial evaluating Cipralex (escitalopram) for depressive symptoms and chronic low back pain has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cipralex (citalopram)

Snippet

Sponsor: Martin-Luther-Universität Halle-Wittenberg | Conditions: Low Back Pain, Depression | Phase 4 | Status: WITHDRAWN